BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  Bristol-Myers Squibb Company And Sanofi-Aventis (France) Plavix Inferior To Standard Drug In Stroke Study

  November 14, 2005

   · 

  1 min read
• FDA

  FDA Approves New Indication For Merck & Co., Inc.'s INVANZ(R) For The Treatment Of Moderate To Severe Complicated Foot Infection In Diabetic Patients Without Osteomyelitis

  November 14, 2005

   · 

  1 min read
• Business

  iVOW, Inc. Reports Third Quarter Results

  November 14, 2005

   · 

  5 min read
• Business

  Cell Therapeutics, Inc. Reports Third Quarter 2005 Financial Results

  November 14, 2005

   · 

  4 min read
• Drug Development

  Bristol-Myers Squibb Company’s BARACLUDE(TM) Two-Year Data Analysis Did Not Detect Emergence Of Resistance In Nucleoside-Naive Chronic Hepatitis B Patients

  November 14, 2005

   · 

  9 min read
• Drug Development

  Nuvelo, Inc. Phase 2a Trial Results Show rNAPc2 Is Well Tolerated In Patients With ACS

  November 14, 2005

   · 

  7 min read
• Genetown

  Momenta Pharmaceuticals, Inc. Selected To Join NASDAQ Biotechnology Index

  November 14, 2005

   · 

  2 min read
• Deals

  Fuji Pharmaceutical Co., Ltd. And, JCR Pharmaceuticals Dissolve Partnership In Renal Anemia Drug Development

  November 14, 2005

   · 

  1 min read
• Business

  MINRAD Inc. Announces Third Quarter Results

  November 14, 2005

   · 

  7 min read
• Business

  Sunesis Pharmaceuticals, Inc. Reports Third Quarter 2005 Financial Results

  November 14, 2005

   · 

  7 min read